NVST

Envista Holdings Corp Health Care Dental Equipment & Supplies Russell 3000
$23.51Close $3.9BMarket cap $18.95 – $30.2652-week range Nov 4, 2026Next report · after the close

Highlights

Strengths

  • Earnings growing EPS +111% year on year

Cautions

  • Not in an uptrend 2 of 8 trend conditions
  • Lagging the market RS 35 · weaker than 65% of stocks over 12 months
  • Results soon Nov 4, 2026, in 3 days
  • Financial distress Altman Z″ in the distress zone

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 5, 2026
Off 12-month high 22%
1wk down 0.4% price change
1mo up 0.2% price change
12-month return up 17% market up 11% · its own up 7%
F-score 7 / 9 Strong
Altman Z 1.64 Elevated risk
P/E 81.9× price / earnings
PEG — P/E / EPS growth
P/B 1.2× price / book
Earnings yield up 5.3% EBIT / enterprise value
Cheaper than 77% of the market · cheap
Revenue growth up 8% year on year
EPS growth up 111% latest quarter · -14 pts
Sales growth up 7% latest quarter · -7 pts
ROE up 2% return on equity
Free cash margin up 8% $230.4M FCF
D/E 0.47 long-term debt / equity
Net debt / EBITDA 0.7×
Interest cover —EBIT / interest
Piotroski tests
  • took on more long-term debt
  • gross margin narrowed
  • profitable on its assets
  • generating cash from operations
  • profitability improving
  • profits backed by cash
  • short-term liquidity improved
  • no new shares issued
  • assets working harder

Repair signals

  • Revenue reaccelerating (-2% then +8%)

Trade setup

ATR% 3.0% $0.70 a day · 2×ATR $22.10
RS 35 / 99 vs the universe
Trend 2 / 8 trend template
Relative volume 1.4× vs 50-day average
Up/down volume 0.89 50 sessions
Implied move — no option chain · report Nov 4, 2026
Trend template · 2 of 8
  • 200-day average rising for a month: passes
  • Within 25% of the 52-week high: passes

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
Last reported Aug 5, 2026
Results reaction Aug 5, 2026-2% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $2.7B +8% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.9B FY2021 · $2.5B FY2022 · $2.6B FY2023 · $2.6B FY2024 · $2.5B FY2025 · $2.7B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $47.0M back to a profit
-$2B $0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $33.3M FY2021 · $340.5M FY2022 · $243.1M FY2023 · -$100.2M FY2024 · -$1.1B FY2025 · $47.0M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $230.4M -24% on FY2024
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $236.2M FY2021 · $306.9M FY2022 · $107.0M FY2023 · $217.5M FY2024 · $302.7M FY2025 · $230.4M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 55%
  • Net 2%
  • Free cash 8%
-50% 0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 55% · Net 2% · Free cash 12% FY2021 · Gross 57% · Net 14% · Free cash 12% FY2022 · Gross 57% · Net 9% · Free cash 4% FY2023 · Gross 56% · Net -4% · Free cash 8% FY2024 · Gross 55% · Net -45% · Free cash 12% FY2025 · Gross 55% · Net 2% · Free cash 8%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $236.6M net debt
  • Cash
  • Long-term debt
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $888.9M · Long-term debt $907.7M FY2021 · Cash $1.1B · Long-term debt $883.4M FY2022 · Cash $606.9M · Long-term debt $870.7M FY2023 · Cash $940.0M · Long-term debt $1.4B FY2024 · Cash $1.1B · Long-term debt $1.3B FY2025 · Cash $1.2B · Long-term debt $1.4B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 163.80m +2.4% since FY2020
172.20m 160m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 160m FY2021 · 161.60m FY2022 · 163.20m FY2023 · 171.50m FY2024 · 172.20m FY2025 · 163.80m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $1.9B $2.5B $2.6B $2.6B $2.5B $2.7B
Gross margin 55% 57% 57% 56% 55% 55%
Operating income $43.5M $306.2M $319.2M $31.5M -$1.0B $216.1M
Net income $33.3M $340.5M $243.1M -$100.2M -$1.1B $47.0M
Net margin 2% 14% 9% -4% -45% 2%
Earnings per share $0.20 $1.92 $1.37 -$0.60 -$6.50 $0.28
Free cash flow $236.2M $306.9M $107.0M $217.5M $302.7M $230.4M
Free cash margin 12% 12% 4% 8% 12% 8%
Cash $888.9M $1.1B $606.9M $940.0M $1.1B $1.2B
Long-term debt $907.7M $883.4M $870.7M $1.4B $1.3B $1.4B
Shareholders' equity $3.7B $4.1B $4.2B $4.2B $2.9B $3.1B
Shares outstanding 160m 161.60m 163.20m 171.50m 172.20m 163.80m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 5, 2026 Quarterly ↗ Jul 3, 2026 33d
May 6, 2026 Quarterly ↗ Apr 3, 2026 33d
Feb 12, 2026 Annual ↗ Dec 31, 2025 43d
Oct 30, 2025 Quarterly ↗ Sep 26, 2025 34d
Jul 31, 2025 Quarterly ↗ Jun 27, 2025 34d
May 1, 2025 Quarterly ↗ Mar 28, 2025 34d
Feb 13, 2025 Annual ↗ Dec 31, 2024 44d
Oct 30, 2024 Quarterly ↗ Sep 27, 2024 33d
Aug 7, 2024 Quarterly ↗ Jun 28, 2024 40d
May 1, 2024 Quarterly ↗ Mar 29, 2024 33d
Feb 15, 2024 Annual ↗ Dec 31, 2023 46d
Nov 1, 2023 Quarterly ↗ Sep 29, 2023 33d

Current reports